235 related articles for article (PubMed ID: 15920040)
21. Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT.
Strojek K; Bebakar WM; Khutsoane DT; Pesic M; Smahelová A; Thomsen HF; Kalra S
Curr Med Res Opin; 2009 Dec; 25(12):2887-94. PubMed ID: 19821654
[TBL] [Abstract][Full Text] [Related]
22. Improved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type 1 diabetes receiving morning, evening, or split dose insulin glargine.
Garg SK; Gottlieb PA; Hisatomi ME; D'Souza A; Walker AJ; Izuora KE; Chase HP
Diabetes Res Clin Pract; 2004 Oct; 66(1):49-56. PubMed ID: 15364161
[TBL] [Abstract][Full Text] [Related]
23. Optimizing glycemic control with insulin glargine.
Williams JB
Diabetes Technol Ther; 2003; 5(3):471-3. PubMed ID: 12828834
[No Abstract] [Full Text] [Related]
24. The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study.
Fischer JS; McLaughlin T; Loza L; Beauchamp R; Schwartz S; Kipnes M
Curr Med Res Opin; 2004 Nov; 20(11):1703-10. PubMed ID: 15537471
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and Safety of Self-Titration Algorithms of Insulin Glargine 300 units/mL in Individuals with Uncontrolled Type 2 Diabetes Mellitus (The Korean TITRATION Study): A Randomized Controlled Trial.
Bae JH; Ahn CH; Yang YS; Moon SJ; Kwak SH; Jung HS; Park KS; Cho YM
Diabetes Metab J; 2022 Jan; 46(1):71-80. PubMed ID: 34130445
[TBL] [Abstract][Full Text] [Related]
26. Glulisine versus human regular insulin in combination with glargine in noncritically ill hospitalized patients with type 2 diabetes: a randomized double-blind study.
Meyer C; Boron A; Plummer E; Voltchenok M; Vedda R
Diabetes Care; 2010 Dec; 33(12):2496-501. PubMed ID: 20805258
[TBL] [Abstract][Full Text] [Related]
27. Comparison of weight-based insulin titration (WIT) and glucose-based insulin titration using basal-bolus algorithm in hospitalized patients with type 2 diabetes: a multicenter, randomized, clinical study.
Zhang X; Zhang T; Xiang G; Wang W; Li Y; Du T; Zhao Y; Mosha SS; Li W
BMJ Open Diabetes Res Care; 2020 Sep; 8(1):. PubMed ID: 32933950
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of patient-led versus physician-led titration of basal insulin in patients with uncontrolled type 2 diabetes: a meta-analysis of randomized controlled trials.
Castellana M; Procino F; Sardone R; Trimboli P; Giannelli G
BMJ Open Diabetes Res Care; 2020 Jul; 8(1):. PubMed ID: 32636220
[TBL] [Abstract][Full Text] [Related]
29. Piloting a novel algorithm for glucose control in the coronary care unit: the RECREATE (REsearching Coronary REduction by Appropriately Targeting Euglycemia) trial.
Nerenberg KA; Goyal A; Xavier D; Sigamani A; Ng J; Mehta SR; Díaz R; Kosiborod M; Yusuf S; Gerstein HC;
Diabetes Care; 2012 Jan; 35(1):19-24. PubMed ID: 22074724
[TBL] [Abstract][Full Text] [Related]
30. Insulin degludec in a simple or stepwise titration algorithm in a Japanese population of patients with type 2 diabetes: a randomized, 26-week, treat-to-target trial.
Kadowaki T; Jinnouchi H; Kaku K; Hersløv ML; Hyllested-Winge J; Nakamura S
Diabetol Int; 2017 Mar; 8(1):87-94. PubMed ID: 30603311
[TBL] [Abstract][Full Text] [Related]
31. Long-acting subcutaneously administered insulin for glycemic control immediately after cardiac surgery.
Aggarwal A; Rawn JD; Pendergrass ML; Garg RK
Endocr Pract; 2011; 17(4):558-62. PubMed ID: 21846617
[TBL] [Abstract][Full Text] [Related]
32. Inpatient glycemic control on the vascular surgery service.
Theilen BM; Gritzke KA; Knutsen PG; Riek AE; McGill JB; Sicard GA; Tobin GS
Endocr Pract; 2008 Mar; 14(2):185-91. PubMed ID: 18308656
[TBL] [Abstract][Full Text] [Related]
33. LOGIC-insulin algorithm-guided versus nurse-directed blood glucose control during critical illness: the LOGIC-1 single-center, randomized, controlled clinical trial.
Van Herpe T; Mesotten D; Wouters PJ; Herbots J; Voets E; Buyens J; De Moor B; Van den Berghe G
Diabetes Care; 2013 Feb; 36(2):188-94. PubMed ID: 22961576
[TBL] [Abstract][Full Text] [Related]
34. Initiate Insulin by Aggressive Titration and Education (INITIATE): a randomized study to compare initiation of insulin combination therapy in type 2 diabetic patients individually and in groups.
Yki-Järvinen H; Juurinen L; Alvarsson M; Bystedt T; Caldwell I; Davies M; Lahdenperä S; Nijpels G; Vähätalo M
Diabetes Care; 2007 Jun; 30(6):1364-9. PubMed ID: 17384341
[TBL] [Abstract][Full Text] [Related]
35. Treat-to-target insulin titration algorithms when initiating long or intermediate acting insulin in type 2 diabetes.
Strange P
J Diabetes Sci Technol; 2007 Jul; 1(4):540-8. PubMed ID: 19885117
[TBL] [Abstract][Full Text] [Related]
36. Glycemic control with use of insulin glargine after cardiothoracic surgery: a retrospective study.
Ergin AB; Nasr G; Yared JP; Bena J; Nasr C
Endocr Pract; 2013; 19(3):485-93. PubMed ID: 23425653
[TBL] [Abstract][Full Text] [Related]
37. Insulin subcutaneous application vs. continuous infusion for postoperative blood glucose control in patients with non-insulin-dependent diabetes mellitus.
González-Michaca L; Ahumada M; Ponce-de-León S
Arch Med Res; 2002; 33(1):48-52. PubMed ID: 11825631
[TBL] [Abstract][Full Text] [Related]
38. Starting glargine in insulin-naïve type 2 diabetic patients based on body mass index is safe.
Franco DR; Baptista J; Abreu FR; Batista RB; Eliaschewitz FG
World J Diabetes; 2014 Feb; 5(1):69-75. PubMed ID: 24567803
[TBL] [Abstract][Full Text] [Related]
39. Best Practices and Tools for Titrating Basal Insulins: Expert Opinion from an Indian Panel via the Modified Delphi Consensus Method.
Jain SM; Seshadri K; Unnikrishnan AG; Chawla M; Kalra P; Vipin VP; Ravishankar E; Chordia J; Das S; Wasir J; Bandookwala SM; Deka N; Agarwal G; Vijaykumar G; Erande S
Diabetes Ther; 2020 Mar; 11(3):621-632. PubMed ID: 32009224
[TBL] [Abstract][Full Text] [Related]
40. Appropriate Titration of Basal Insulin in Type 2 Diabetes and the Potential Role of the Pharmacist.
Patel D; Triplitt C; Trujillo J
Adv Ther; 2019 May; 36(5):1031-1051. PubMed ID: 30900198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
